UGT2B15
Basic information
Region (hg38): 4:68646597-68670652
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT2B15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 43 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 43 | 2 | 3 |
Variants in UGT2B15
This is a list of pathogenic ClinVar variants found in the UGT2B15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-68647117-T-C | Benign (Apr 05, 2018) | |||
4-68647159-C-T | not specified | Uncertain significance (Oct 20, 2021) | ||
4-68647172-T-C | not specified | Uncertain significance (Jul 02, 2024) | ||
4-68647190-C-T | not specified | Uncertain significance (Aug 19, 2023) | ||
4-68647193-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
4-68647211-C-T | not specified | Uncertain significance (Aug 31, 2023) | ||
4-68647213-A-G | not specified | Uncertain significance (Oct 26, 2024) | ||
4-68647238-T-A | not specified | Uncertain significance (Dec 17, 2023) | ||
4-68647256-C-A | not specified | Uncertain significance (Oct 25, 2024) | ||
4-68647268-G-A | not specified | Uncertain significance (May 26, 2024) | ||
4-68647289-G-A | Likely benign (Feb 01, 2023) | |||
4-68647289-G-T | not specified | Uncertain significance (Oct 25, 2022) | ||
4-68647292-T-C | not specified | Uncertain significance (Sep 08, 2024) | ||
4-68647337-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
4-68647366-A-G | not specified | Uncertain significance (May 18, 2023) | ||
4-68654064-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
4-68654071-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
4-68654097-A-T | not specified | Uncertain significance (Jun 11, 2021) | ||
4-68654105-A-T | not specified | Likely benign (Dec 06, 2022) | ||
4-68654131-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
4-68654136-G-C | not specified | Uncertain significance (Mar 25, 2024) | ||
4-68654163-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
4-68654167-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
4-68654197-T-C | not specified | Uncertain significance (Aug 03, 2022) | ||
4-68654199-G-A | not specified | Uncertain significance (Dec 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UGT2B15 | protein_coding | protein_coding | ENST00000338206 | 6 | 23999 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.29e-21 | 0.000127 | 125682 | 0 | 58 | 125740 | 0.000231 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.874 | 313 | 272 | 1.15 | 0.0000127 | 3486 |
Missense in Polyphen | 83 | 82.635 | 1.0044 | 1155 | ||
Synonymous | -1.55 | 117 | 97.5 | 1.20 | 0.00000468 | 969 |
Loss of Function | -1.20 | 28 | 21.9 | 1.28 | 0.00000110 | 272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000471 | 0.000470 |
Ashkenazi Jewish | 0.000924 | 0.000893 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000252 | 0.000246 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000659 | 0.0000653 |
Other | 0.000333 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: UDPGTs are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isozyme displays activity toward several classes of xenobiotic substrates, including simple phenolic compounds, 7-hydroxylated coumarins, flavonoids, anthraquinones, and certain drugs and their hydroxylated metabolites. It also catalyzes the glucuronidation of endogenous estrogens and androgens.;
- Pathway
- Benzodiazepine Pathway, Pharmacokinetics;Retinol metabolism - Homo sapiens (human);Steroid hormone biosynthesis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);Tamoxifen Pathway, Pharmacokinetics;Valproic Acid Pathway, Pharmacokinetics;Pathway_PA165986194 -need delete;Acetaminophen Pathway, Pharmacokinetics;Morphine Metabolism Pathway;Morphine Action Pathway;Acetaminophen Metabolism Pathway;Tamoxifen metabolism;Glucuronidation;Glucuronidation;Phase II - Conjugation of compounds;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Biological oxidations;Metabolism;Linoleate metabolism;Vitamin A (retinol) metabolism;Xenobiotics metabolism;Porphyrin metabolism
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.887
- rvis_EVS
- 1.38
- rvis_percentile_EVS
- 94.57
Haploinsufficiency Scores
- pHI
- 0.121
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0787
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- xenobiotic metabolic process;steroid metabolic process;cellular glucuronidation
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- retinoic acid binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity